Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Oct;38(4):289–305. doi: 10.1111/j.1365-2125.1994.tb04357.x

Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

W H Aellig 1
PMCID: PMC1364771  PMID: 7833218

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernethy D. R., Winterbottom L. M. Forearm vascular alpha 1-adrenergic blockade by verapamil. Clin Pharmacol Ther. 1990 Jun;47(6):755–759. doi: 10.1038/clpt.1990.104. [DOI] [PubMed] [Google Scholar]
  2. Aellig W. H. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol. 1981 Mar;11(3):237–243. doi: 10.1111/j.1365-2125.1981.tb00527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aellig W. H. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors. Adv Neurol. 1982;33:321–324. [PubMed] [Google Scholar]
  4. Aellig W. H. Direct effects of vasoactive substances on superficial human veins in vivo. Int Angiol. 1985 Apr-Jun;4(2):235–242. [PubMed] [Google Scholar]
  5. Aellig W. H. Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J. 1976;52SUPPL:21–23. [PubMed] [Google Scholar]
  6. Aellig W. H. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man. Eur J Clin Pharmacol. 1983;25(6):759–762. doi: 10.1007/BF00542515. [DOI] [PubMed] [Google Scholar]
  7. Aellig W. H. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man. Eur J Clin Pharmacol. 1984;26(2):239–242. doi: 10.1007/BF00630292. [DOI] [PubMed] [Google Scholar]
  8. Aellig W. H. Methods for studying drug effects on superficial human veins. Methods Find Exp Clin Pharmacol. 1985 Jun;7(6):321–324. [PubMed] [Google Scholar]
  9. Aellig W. H., Rosenthaler J. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration. Eur J Clin Pharmacol. 1986;30(5):581–584. doi: 10.1007/BF00542418. [DOI] [PubMed] [Google Scholar]
  10. Aellig W. H. Superficial hand and foot veins show no difference in sensitivity to constrictor agents. Clin Pharmacol Ther. 1990 Jul;48(1):96–101. doi: 10.1038/clpt.1990.122. [DOI] [PubMed] [Google Scholar]
  11. Aellig W. H. Venentonisierende Wirkung von Ergotalkaloiden, untersucht an oberflächlichen Handvenen in situ. Cardiology. 1976;61 Suppl 1:302–308. doi: 10.1159/000169823. [DOI] [PubMed] [Google Scholar]
  12. Aellig W. H. Venoconstrictor effect of dihydroergotamine in superficial hand veins. Eur J Clin Pharmacol. 1974;7(2):137–139. doi: 10.1007/BF00561328. [DOI] [PubMed] [Google Scholar]
  13. Alradi A. O., Carruthers S. G. Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity. Clin Pharmacol Ther. 1985 Nov;38(5):495–502. doi: 10.1038/clpt.1985.214. [DOI] [PubMed] [Google Scholar]
  14. Altenkirch H. U., Fransson L., Koch G. Assessment of arterial and venous circulation in upper and lower extremities by venous occlusion strain gauge plethysmography. Normal values and reproducibility. Vasa. 1989;18(2):140–145. [PubMed] [Google Scholar]
  15. Aminu J., Vere D. W. A longitudinal study of the mechanisms of action of debrisoquine and propranolol. Br J Clin Pharmacol. 1978 Jul;6(1):43–50. doi: 10.1111/j.1365-2125.1978.tb01680.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ando S., Imaizumi T., Harada S., Hirooka Y., Takeshita A. Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J Hypertens. 1992 May;10(5):451–457. doi: 10.1097/00004872-199205000-00008. [DOI] [PubMed] [Google Scholar]
  17. Arner M., Högestätt E. D. Contractile effects of noradrenaline and 5-hydroxytryptamine in human hand veins: a pharmacological receptor characterization. Acta Physiol Scand. 1986 Oct;128(2):209–217. doi: 10.1111/j.1748-1716.1986.tb07968.x. [DOI] [PubMed] [Google Scholar]
  18. Arner M., Högestätt E. D. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. Acta Physiol Scand. 1991 Jun;142(2):165–172. doi: 10.1111/j.1748-1716.1991.tb09144.x. [DOI] [PubMed] [Google Scholar]
  19. Arner M., Högestätt E. D. Influence of temperature and extracellular pH on contractile responses in isolated human hand veins. Pharmacol Toxicol. 1990 Aug;67(2):141–146. doi: 10.1111/j.1600-0773.1990.tb00800.x. [DOI] [PubMed] [Google Scholar]
  20. Arner M., Högestätt E. D., Uski T. K. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848. Acta Physiol Scand. 1991 Jan;141(1):79–86. doi: 10.1111/j.1748-1716.1991.tb09047.x. [DOI] [PubMed] [Google Scholar]
  21. Awan N. A., Mason D. T. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril. Am Heart J. 1982 Nov;104(5 Pt 2):1127–1136. doi: 10.1016/0002-8703(82)90041-2. [DOI] [PubMed] [Google Scholar]
  22. BARBEY K., BARBEY P. EIN NEUER PLETHYSMOGRAPH ZUR MESSUNG DER EXTREMITAETENDURCHBLUTUNG. Z Kreislaufforsch. 1963 Nov;52:1129–1140. [PubMed] [Google Scholar]
  23. BURCH G. E., MURTADHA M. A study of the venomotor tone in a short intact venous segment of the forearm of man. Am Heart J. 1956 Jun;51(6):807–828. doi: 10.1016/0002-8703(56)90225-3. [DOI] [PubMed] [Google Scholar]
  24. Bartelink M. L., Wollersheim H., Theeuwes A., van Duren D., Thien T. Changes in skin blood flow during the menstrual cycle: the influence of the menstrual cycle on the peripheral circulation in healthy female volunteers. Clin Sci (Lond) 1990 May;78(5):527–532. doi: 10.1042/cs0780527. [DOI] [PubMed] [Google Scholar]
  25. Barthel W. An attempt to characterize alpha-adrenoceptors on human dorsal foot veins in situ. Int J Clin Pharmacol Ther Toxicol. 1993 Jun;31(6):267–270. [PubMed] [Google Scholar]
  26. Barthel W., Glusa E., Koth W. Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ. Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):63–69. [PubMed] [Google Scholar]
  27. Bedarida G. V., Bushell E., Haefeli W. E., Blaschke T. F., Hoffman B. B. Responsiveness to bradykinin in veins of hypercholesterolemic humans. Circulation. 1993 Dec;88(6):2754–2761. doi: 10.1161/01.cir.88.6.2754. [DOI] [PubMed] [Google Scholar]
  28. Bedarida G., Kim D., Blaschke T. F., Hoffman B. B. Venodilation in Raynaud's disease. Lancet. 1993 Dec 11;342(8885):1451–1454. doi: 10.1016/0140-6736(93)92932-j. [DOI] [PubMed] [Google Scholar]
  29. Beermann C., Schloos J., Belz G. G. Constriction of human dorsal hand veins in vivo with several vasoconstrictors and the influence of oral administration of carvedilol. J Cardiovasc Pharmacol. 1992;19 (Suppl 1):S12–S17. doi: 10.1097/00005344-199219001-00004. [DOI] [PubMed] [Google Scholar]
  30. Beermann C., Schloos J., Belz G. G. Oral administration of carvedilol and prazosin inhibits the prostaglandin F2 alpha- and noradrenaline-induced contraction of human hand veins in vivo. Clin Investig. 1992;70 (Suppl 1):S13–S19. doi: 10.1007/BF00207606. [DOI] [PubMed] [Google Scholar]
  31. Belz G. G., Beermann C., Schloos J., Kleinbloesem C. H. The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins. Br J Clin Pharmacol. 1989 Nov;28(5):608–611. doi: 10.1111/j.1365-2125.1989.tb03550.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Belz G. G., Beermann C. Venodilatory effects of nicorandil in healthy volunteers. J Cardiovasc Pharmacol. 1992;20 (Suppl 3):S57–S58. doi: 10.1097/00005344-199206203-00011. [DOI] [PubMed] [Google Scholar]
  33. Benjamin N., Collier J. G., Webb D. J. Angiotensin II augments sympathetically induced venoconstriction in man. Clin Sci (Lond) 1988 Oct;75(4):337–340. doi: 10.1042/cs0750337. [DOI] [PubMed] [Google Scholar]
  34. Benjamin N., Vallance P. Local control of human peripheral vascular tone: implications for drug therapy. Clin Sci (Lond) 1991 Mar;80(3):183–190. doi: 10.1042/cs0800183. [DOI] [PubMed] [Google Scholar]
  35. Blauw G. J., van Brummelen P., Chang P. C., Vermeij P., van Zwieten P. A. Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related. J Cardiovasc Pharmacol. 1989 Jul;14(1):14–21. doi: 10.1097/00005344-198907000-00004. [DOI] [PubMed] [Google Scholar]
  36. Blöchl-Daum B., Korn A., Wolzt M., Schmidt E., Eichler H. G. In vivo studies on alpha-adrenergic receptor subtypes in human veins. Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):302–307. doi: 10.1007/BF00183004. [DOI] [PubMed] [Google Scholar]
  37. Blöchl-Daum B., Schuller-Petrovic S., Wolzt M., Korn A., Böhler K., Eichler H. G. Primary defect in alpha-adrenergic responsiveness in patients with varicose veins. Clin Pharmacol Ther. 1991 Jan;49(1):49–52. doi: 10.1038/clpt.1991.9. [DOI] [PubMed] [Google Scholar]
  38. Blöchl-Daum B., Vierhapper H., Eichler H. G., Waldhäusl W. Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins. Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:90–96. [PubMed] [Google Scholar]
  39. Bodelsson M., Arneklo-Nobin B., Nobin A., Owman C., Sollerman C., Törnebrandt K. Cooling enhances alpha 2-adrenoceptor-mediated vasoconstriction in human hand veins. Acta Physiol Scand. 1990 Mar;138(3):283–291. doi: 10.1111/j.1748-1716.1990.tb08848.x. [DOI] [PubMed] [Google Scholar]
  40. Bodelsson M., Arneklo-Nobin B., Törnebrandt K. Effect of cooling on smooth muscle response to 5-hydroxytryptamine in human hand veins. Acta Physiol Scand. 1990 Nov;140(3):331–339. doi: 10.1111/j.1748-1716.1990.tb09007.x. [DOI] [PubMed] [Google Scholar]
  41. Bodelsson M., Törnebrandt K., Bertilsson I. L., Arneklo-Nobin B. Heterogeneity of contractile 5-HT receptors in human hand veins. Eur J Pharmacol. 1992 Sep 4;219(3):455–460. doi: 10.1016/0014-2999(92)90488-p. [DOI] [PubMed] [Google Scholar]
  42. Bodmer C. W., Patrick A. W., How T. V., Williams G. Exaggerated sensitivity to NE-induced vasoconstriction in IDDM patients with microalbuminuria. Possible etiology and diagnostic implications. Diabetes. 1992 Feb;41(2):209–214. doi: 10.2337/diab.41.2.209. [DOI] [PubMed] [Google Scholar]
  43. Borton M., Neligan M., Wood F., Dervan P., Goggins K., Docherty J. R. Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein. Br J Clin Pharmacol. 1990;30 (Suppl 1):107S–108S. doi: 10.1111/j.1365-2125.1990.tb05476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Breithaupt K., Belz G. G., Kempinski S., Schicketanz K. H., Dieterich H. A. Einfluss von oral verabreichtem Enoximon auf Herzleistung, arterielle Ruhedurchblutung und auf die vasokonstriktorische Wirkung von lokalen Noradrenalininfusionen in die menschliche Handvene. Z Kardiol. 1991;80 (Suppl 4):15–20. [PubMed] [Google Scholar]
  45. Breithaupt K., Belz G. G., Kempinski S., Schicketanz K. H., Dieterich H. A. The effects of oral enoximone on cardiac performance, calf arterial blood flow, and constrictor effects of norepinephrine infused into hand veins in humans. J Cardiovasc Pharmacol. 1990 Sep;16(3):349–353. doi: 10.1097/00005344-199009000-00001. [DOI] [PubMed] [Google Scholar]
  46. Bönner G., Preis S., Schunk U., Wagmann M., Chrosch R., Toussaint C. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J Cardiovasc Pharmacol. 1992;20 (Suppl 9):S21–S27. [PubMed] [Google Scholar]
  47. Caleri D., Marabini S., Panconesi A., Pietrini U. A pharmacological approach to the analgesizing mechanism of somatostatin in cluster headache. Ric Clin Lab. 1987 Apr-Jun;17(2):155–162. [PubMed] [Google Scholar]
  48. Calver A., Collier J., Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci (Lond) 1991 Nov;81(5):695–700. doi: 10.1042/cs0810695. [DOI] [PubMed] [Google Scholar]
  49. Campbell P. M., LeRoy E. C. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum. 1975 May;4(4):351–368. doi: 10.1016/0049-0172(75)90017-7. [DOI] [PubMed] [Google Scholar]
  50. Capewell S., Capewell A. 'First dose' hypotension and venodilatation. Br J Clin Pharmacol. 1991 Feb;31(2):213–215. doi: 10.1111/j.1365-2125.1991.tb05522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Capewell S., Taverner D., Hannan W. J., Muir A. L. Acute and chronic arterial and venous effects of captopril in congestive cardiac failure. BMJ. 1989 Oct 14;299(6705):942–945. doi: 10.1136/bmj.299.6705.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Clarke J. G., Benjamin N., Larkin S. W., Webb D. J., Davies G. J., Maseri A. Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol. 1989 Dec;257(6 Pt 2):H2033–H2035. doi: 10.1152/ajpheart.1989.257.6.H2033. [DOI] [PubMed] [Google Scholar]
  53. Cleland J. G., Dargie H. J., McAlpine H., Ball S. G., Morton J. J., Robertson J. I., Ford I. Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) 1985 Nov 9;291(6505):1309–1312. doi: 10.1136/bmj.291.6505.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Clements I. P., Strelow D. A., Becker G. P., Vlietstra R. E., Brown M. L. Radionuclide evaluation of peripheral circulatory dynamics: new clinical application of blood pool scintigraphy for measuring limb venous volume, capacity, and blood flow. Am Heart J. 1981 Dec;102(6 Pt 1):980–983. doi: 10.1016/0002-8703(81)90480-4. [DOI] [PubMed] [Google Scholar]
  55. Collier J. G., Dawnay N. A., Nachev C., Robinson B. F. Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A. Br J Pharmacol. 1972 Feb;44(2):286–293. doi: 10.1111/j.1476-5381.1972.tb07265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Collier J. G., Lorge R. E., Robinson B. F. Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol. 1978 Jan;5(1):35–44. doi: 10.1111/j.1365-2125.1978.tb01595.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Collier J. G., Nachev C., Robinson B. F. A new method for studying the pharmacology of the superficial veins in conscious man. Br J Pharmacol. 1970 Nov;40(3):574P–575P. [PMC free article] [PubMed] [Google Scholar]
  58. Collier J. G., Nachev C., Robinson B. F. Comparison of blockade at alpha-adrenoceptors by thymoxamine and phentolamine in peripheral arteries and veins of man. Br J Pharmacol. 1972 Feb;44(2):294–300. doi: 10.1111/j.1476-5381.1972.tb07266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Collier J. G., Nachev C., Robinson B. F. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci. 1972 Sep;43(3):455–467. doi: 10.1042/cs0430455. [DOI] [PubMed] [Google Scholar]
  60. Collier J. G., Robinson B. F. Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels. Clin Sci Mol Med. 1974 Aug;47(2):189–192. doi: 10.1042/cs0470189. [DOI] [PubMed] [Google Scholar]
  61. Collier J., Vallance P. Biphasic response to acetylcholine in human veins in vivo: the role of the endothelium. Clin Sci (Lond) 1990 Jan;78(1):101–104. doi: 10.1042/cs0780101. [DOI] [PubMed] [Google Scholar]
  62. Cowley A. J., Rowley J. M., Stainer K. L., Hampton J. R. Captopril therapy for heart failure. A placebo controlled study. Lancet. 1982 Oct 2;2(8301):730–732. doi: 10.1016/s0140-6736(82)90920-5. [DOI] [PubMed] [Google Scholar]
  63. DEPASQUALE N. P., BURCH G. E. EFFECT OF ANGIOTENSIN II ON THE INTACT FOREARM VEINS OF MAN. Circ Res. 1963 Sep;13:239–245. doi: 10.1161/01.res.13.3.239. [DOI] [PubMed] [Google Scholar]
  64. Dachman W. D., Ford G. A., Blaschke T. F., Hoffman B. B. Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol. 1993 Feb;21(2):241–248. doi: 10.1097/00005344-199302000-00009. [DOI] [PubMed] [Google Scholar]
  65. Dachman W. D., Ford G. A., Hoffman B. B., Blaschke T. F. Bradykinin-induced venodilation is not impaired with aging in humans. J Gerontol. 1992 Sep;47(5):M166–M170. doi: 10.1093/geronj/47.5.m166. [DOI] [PubMed] [Google Scholar]
  66. Docherty J. R., O'Malley K. Ageing and alpha-adrenoceptors. Clin Sci (Lond) 1985;68 (Suppl 10):133s–136s. doi: 10.1042/cs068s133. [DOI] [PubMed] [Google Scholar]
  67. Eichler H. G., Blaschke T. F., Hoffman B. B. Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males. J Cardiovasc Pharmacol. 1990 Aug;16(2):177–181. doi: 10.1097/00005344-199008000-00001. [DOI] [PubMed] [Google Scholar]
  68. Eichler H. G., Blaschke T. F., Kraemer F. B., Ford G. A., Blöchl-Daum B., Hoffman B. B. Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients. Clin Sci (Lond) 1992 Feb;82(2):163–168. doi: 10.1042/cs0820163. [DOI] [PubMed] [Google Scholar]
  69. Eichler H. G., Blöchl-Daum B., Eichler I., Wolzt M., Korn A., Götz M. Normal responsiveness of superficial hand veins to alpha- and beta-adrenergic stimuli in allergic asthma: effects of terbutaline and prednisolone on beta-adrenergic responsiveness. J Allergy Clin Immunol. 1990 Nov;86(5):714–725. doi: 10.1016/s0091-6749(05)80175-7. [DOI] [PubMed] [Google Scholar]
  70. Eichler H. G., Blöchl-Daum B., Kyrle P. A., Gasic S. Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties. J Cardiovasc Pharmacol. 1989 Aug;14(2):248–252. doi: 10.1097/00005344-198908000-00010. [DOI] [PubMed] [Google Scholar]
  71. Eichler H. G., Eichler I., Lewiston N., Blaschke T. F., Hoffman B. B. Responsiveness of superficial hand veins to adrenergic stimuli in patients with cystic fibrosis. Clin Sci (Lond) 1989 Mar;76(3):283–287. doi: 10.1042/cs0760283. [DOI] [PubMed] [Google Scholar]
  72. Eichler H. G., Ford G. A., Blaschke T. F., Swislocki A., Hoffman B. B. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest. 1989 Jan;83(1):108–112. doi: 10.1172/JCI113845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Eichler H. G., Hiremath A., Katzir D., Blaschke T. F., Hoffman B. B. Absence of age-related changes in venous responsiveness to nitroglycerin in vivo in humans. Clin Pharmacol Ther. 1987 Nov;42(5):521–524. doi: 10.1038/clpt.1987.191. [DOI] [PubMed] [Google Scholar]
  74. Eskinder H., Hillard C. J., Olinger G. N., Christensen C. W., Baker J. E., Warltier D. C., Gross G. J. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin. J Pharmacol Exp Ther. 1988 Dec;247(3):941–948. [PubMed] [Google Scholar]
  75. Faxon D. P., Halperin J. L., Creager M. A., Gavras H., Schick E. C., Ryan T. J. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Am Heart J. 1981 May;101(5):548–556. doi: 10.1016/0002-8703(81)90220-9. [DOI] [PubMed] [Google Scholar]
  76. Feldman R. D. A low-sodium diet corrects the defect in beta-adrenergic response in older subjects. Circulation. 1992 Feb;85(2):612–618. doi: 10.1161/01.cir.85.2.612. [DOI] [PubMed] [Google Scholar]
  77. Feldman R. D., Bierbrier G. S. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 1993 Sep 18;342(8873):707–709. doi: 10.1016/0140-6736(93)91708-t. [DOI] [PubMed] [Google Scholar]
  78. Feldman R. D. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest. 1990 Mar;85(3):647–652. doi: 10.1172/JCI114487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Feldman R. D., Freeman D. J., Bierbrier G. S., Anthony S. E., Brown J. E. Beta-adrenergic responsiveness is regulated selectively in hypertension. Clin Pharmacol Ther. 1993 Dec;54(6):654–660. doi: 10.1038/clpt.1993.203. [DOI] [PubMed] [Google Scholar]
  80. Ford G. A., Eichler H. G., Hoffman B. B., Blaschke T. F. Venous responsiveness to atrial natriuretic factor in man. Br J Clin Pharmacol. 1988 Dec;26(6):797–799. doi: 10.1111/j.1365-2125.1988.tb05322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Ford G. A., Hoffman B. B., Vestal R. E., Blaschke T. F. Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol. 1992 Jan;33(1):83–87. doi: 10.1111/j.1365-2125.1992.tb04004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Ford G. A., Katzir D., Blaschke T. F., Hoffman B. B. Responsiveness of peripheral veins to vasodilators and the effect of nifedipine on alpha-adrenergic responsiveness in hypertension. Clin Pharmacol Ther. 1991 Aug;50(2):192–198. doi: 10.1038/clpt.1991.124. [DOI] [PubMed] [Google Scholar]
  83. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  84. GAUER O. H., HENRY J. P. Beitrag zur Homöostase des extraarteriellen Kreislaufs; Volumenregulation als unabhängiger physiologischer Parameter. Klin Wochenschr. 1956 Apr 1;34(13-14):356–366. doi: 10.1007/BF01469349. [DOI] [PubMed] [Google Scholar]
  85. Gascho J. A., Fanelli C., Zelis R. Aging reduces venous distensibility and the venodilatory response to nitroglycerin in normal subjects. Am J Cardiol. 1989 May 15;63(17):1267–1270. doi: 10.1016/0002-9149(89)90188-4. [DOI] [PubMed] [Google Scholar]
  86. Goldman M. P., Fronek A. Anatomy and pathophysiology of varicose veins. J Dermatol Surg Oncol. 1989 Feb;15(2):138–145. doi: 10.1111/j.1524-4725.1989.tb03020.x. [DOI] [PubMed] [Google Scholar]
  87. Haefeli W. E., Bargetzi M. J., Starnes H. F., Blaschke T. F., Hoffman B. B. Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1 beta in humans. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):136–140. doi: 10.1097/00002371-199302000-00009. [DOI] [PubMed] [Google Scholar]
  88. Haefeli W. E., Gumbleton M., Benet L. Z., Hoffman B. B., Blaschke T. F. Comparison of vasodilatory responses to nitroglycerin and its dinitrate metabolites in human veins. Clin Pharmacol Ther. 1992 Dec;52(6):590–596. doi: 10.1038/clpt.1992.196. [DOI] [PubMed] [Google Scholar]
  89. Haefeli W. E., Srivastava N., Kelsey K. T., Wiencke J. K., Hoffman B. B., Blaschke T. F. Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsiveness. Clin Pharmacol Ther. 1993 Apr;53(4):463–468. doi: 10.1038/clpt.1993.52. [DOI] [PubMed] [Google Scholar]
  90. Haefeli W. E., Srivastava N., Kongpatanakul S., Blaschke T. F., Hoffman B. B. Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans. Am J Physiol. 1993 Feb;264(2 Pt 2):H364–H369. doi: 10.1152/ajpheart.1993.264.2.H364. [DOI] [PubMed] [Google Scholar]
  91. Harf L., Arch S., Eskin A. Polypeptide secretion from the eye of Aplysia californica. Brain Res. 1976 Jul 30;111(2):295–299. doi: 10.1016/0006-8993(76)90774-5. [DOI] [PubMed] [Google Scholar]
  92. Harker C. T., Ousley P. J., Harris E. J., Edwards J. M., Taylor L. M., Porter J. M. The effects of cooling on human saphenous vein reactivity to adrenergic agonists. J Vasc Surg. 1990 Jul;12(1):45–49. doi: 10.1067/mva.1990.20311. [DOI] [PubMed] [Google Scholar]
  93. Hasking G. J., Esler M. D., Jennings G. L., Burton D., Johns J. A., Korner P. I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986 Apr;73(4):615–621. doi: 10.1161/01.cir.73.4.615. [DOI] [PubMed] [Google Scholar]
  94. Hassan A. A., Carter G., Tooke J. E. Postural vasoconstriction in women during the normal menstrual cycle. Clin Sci (Lond) 1990 Jan;78(1):39–47. doi: 10.1042/cs0780039. [DOI] [PubMed] [Google Scholar]
  95. Haynes W. G., Webb D. J. Endothelium-dependent modulation of responses to endothelin-I in human veins. Clin Sci (Lond) 1993 Apr;84(4):427–433. doi: 10.1042/cs0840427. [DOI] [PubMed] [Google Scholar]
  96. Hiremath A. N., Hoffman B. B., Blaschke T. F. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers. J Cardiovasc Pharmacol. 1989 Oct;14(4):534–541. doi: 10.1097/00005344-198910000-00004. [DOI] [PubMed] [Google Scholar]
  97. Hiremath A. N., Pershe R. A., Hoffman B. B., Blaschke T. F. Comparison of age-related changes in prostaglandin E1 and beta-adrenergic responsiveness of vascular smooth muscle in adult males. J Gerontol. 1989 Jan;44(1):M13–M17. doi: 10.1093/geronj/44.1.m13. [DOI] [PubMed] [Google Scholar]
  98. Hodsman G. P., Isles C. G., Murray G. D., Usherwood T. P., Webb D. J., Robertson J. I. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):832–834. doi: 10.1136/bmj.286.6368.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hyland L., Docherty J. R. An investigation of age-related changes in pre- and postjunctional alpha-adrenoceptors in human saphenous vein. Eur J Pharmacol. 1985 Aug 27;114(3):361–364. doi: 10.1016/0014-2999(85)90381-4. [DOI] [PubMed] [Google Scholar]
  100. Ikenouchi H., Iizuka M., Sato H., Momomura S., Serizawa T., Sugimoto T. Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure. Jpn Heart J. 1991 Jan;32(1):17–34. doi: 10.1536/ihj.32.17. [DOI] [PubMed] [Google Scholar]
  101. KAISER G. A., ROSS J., Jr, BRAUNWALD E. ALPHA AND BETA ADRENERGIC RECEPTOR MECHANISMS IN THE SYSTEMIC VENOUS BED. J Pharmacol Exp Ther. 1964 May;144:156–162. [PubMed] [Google Scholar]
  102. Kahaleh M. B., Sherer G. K., LeRoy E. C. Endothelial injury in scleroderma. J Exp Med. 1979 Jun 1;149(6):1326–1335. doi: 10.1084/jem.149.6.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Kelleher C., Joyce C., Kelly G., Ferriss J. B. Blood pressure alters during the normal menstrual cycle. Br J Obstet Gynaecol. 1986 May;93(5):523–526. [PubMed] [Google Scholar]
  104. Klein C., Gerber J. G., Payne N. A., Nies A. S. The effect of age on the sensitivity of the alpha 1-adrenoceptor to phenylephrine and prazosin. Clin Pharmacol Ther. 1990 Apr;47(4):535–539. doi: 10.1038/clpt.1990.68. [DOI] [PubMed] [Google Scholar]
  105. Ljutić D., Rumboldt Z. The influence of the atrial natriuretic factor on venous tone in man. Int J Clin Pharmacol Res. 1989;9(4):255–260. [PubMed] [Google Scholar]
  106. Luthra A., Borkowski K. R., Carruthers S. G. Genetic aspects of variability in superficial vein responsiveness to norepinephrine. Clin Pharmacol Ther. 1991 Apr;49(4):355–361. doi: 10.1038/clpt.1991.41. [DOI] [PubMed] [Google Scholar]
  107. Lüscher T. F., Diederich D., Siebenmann R., Lehmann K., Stulz P., von Segesser L., Yang Z. H., Turina M., Grädel E., Weber E. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988 Aug 25;319(8):462–467. doi: 10.1056/NEJM198808253190802. [DOI] [PubMed] [Google Scholar]
  108. Lüscher T. F. Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels. Lung. 1990;168 (Suppl):27–34. doi: 10.1007/BF02718110. [DOI] [PubMed] [Google Scholar]
  109. Lüscher T. F., Yang Z., Tschudi M., von Segesser L., Stulz P., Boulanger C., Siebenmann R., Turina M., Bühler F. R. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res. 1990 Apr;66(4):1088–1094. doi: 10.1161/01.res.66.4.1088. [DOI] [PubMed] [Google Scholar]
  110. Manyari D. E., Malkinson T. J., Robinson V., Smith E. R., Cooper K. E. Acute changes in forearm venous volume and tone using radionuclide plethysmography. Am J Physiol. 1988 Oct;255(4 Pt 2):H947–H952. doi: 10.1152/ajpheart.1988.255.4.H947. [DOI] [PubMed] [Google Scholar]
  111. Martin S. A., Alexieva S., Carruthers S. G. The influence of age on dorsal hand vein responsiveness to norepinephrine. Clin Pharmacol Ther. 1986 Sep;40(3):257–260. doi: 10.1038/clpt.1986.172. [DOI] [PubMed] [Google Scholar]
  112. Matucci-Cerinic M., Pietrini U., Marabini S. Local venomotor response to intravenous infusion of substance P and glyceryl trinitrate in systemic sclerosis. Clin Exp Rheumatol. 1990 Nov-Dec;8(6):561–565. [PubMed] [Google Scholar]
  113. McEwan J. R., Benjamin N., Larkin S., Fuller R. W., Dollery C. T., MacIntyre I. Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation. 1988 May;77(5):1072–1080. doi: 10.1161/01.cir.77.5.1072. [DOI] [PubMed] [Google Scholar]
  114. McPherson M. A., Dormer R. L., Bradbury N. A., Dodge J. A., Goodchild M. C. Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet. 1986 Nov 1;2(8514):1007–1008. doi: 10.1016/s0140-6736(86)92616-4. [DOI] [PubMed] [Google Scholar]
  115. Miller J. W., Streeten D. H. Vascular responsiveness to norepinephrine in sympathicotonic orthostatic intolerance. J Lab Clin Med. 1990 May;115(5):549–558. [PubMed] [Google Scholar]
  116. Molderings G. J., Werner K., Likungu J., Göthert M. Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):371–377. doi: 10.1007/BF00169451. [DOI] [PubMed] [Google Scholar]
  117. Mostbeck A., Partsch H., Peschl L. Anderungen der Blutvolumenverteilung im Ganzkörper unter physikalischen und pharmakologischen Massnahmen. Vasa. 1977;6(2):137–142. [PubMed] [Google Scholar]
  118. Müller-Schweinitzer E. Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):699–703. doi: 10.1007/BF00165637. [DOI] [PubMed] [Google Scholar]
  119. Müller-Schweinitzer E. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine. Naunyn Schmiedebergs Arch Pharmacol. 1976 Oct;295(1):41–44. doi: 10.1007/BF00509770. [DOI] [PubMed] [Google Scholar]
  120. Müller-Schweinitzer E. Interaction of cyclosporine-A with the renin-angiotensin system in canine veins. Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):252–257. doi: 10.1007/BF00168977. [DOI] [PubMed] [Google Scholar]
  121. Müller-Schweinitzer E. Pharmacological actions of the main metabolites of dihydroergotamine. Eur J Clin Pharmacol. 1984;26(6):699–705. doi: 10.1007/BF00541928. [DOI] [PubMed] [Google Scholar]
  122. Müller-Schweinitzer E. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):805–810. doi: 10.1097/00005344-198709010-00023. [DOI] [PubMed] [Google Scholar]
  123. Müller-Schweinitzer E., Tapparelli C. Methylergometrine, an active metabolite of methysergide. Cephalalgia. 1986 Mar;6(1):35–41. doi: 10.1046/j.1468-2982.1986.0601035.x. [DOI] [PubMed] [Google Scholar]
  124. Müller-Schweinitzer E. The recording of venous compliance in the conscious dog: a method for the assessment of venoconstrictor agents. J Pharmacol Methods. 1984 Aug;12(1):53–58. doi: 10.1016/0160-5402(84)90006-8. [DOI] [PubMed] [Google Scholar]
  125. Nachev C., Collier J., Robinson B. Simplified method for measuring compliance of superficial veins. Cardiovasc Res. 1971 Jan;5(1):147–156. doi: 10.1093/cvr/5.1.147. [DOI] [PubMed] [Google Scholar]
  126. O'Grady J., Oh V., Turner P. Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man. Eur J Clin Pharmacol. 1978 Nov 16;14(2):83–85. doi: 10.1007/BF00607435. [DOI] [PubMed] [Google Scholar]
  127. O'Malley K., Docherty J. R., Kelly J. G. Adrenoceptor status and cardiovascular function in ageing. J Hypertens Suppl. 1988 Nov;6(1):S59–S62. [PubMed] [Google Scholar]
  128. Palmer R. M., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251–1256. doi: 10.1016/s0006-291x(88)81362-7. [DOI] [PubMed] [Google Scholar]
  129. Pan H. Y., Hoffman B. B., Pershe R. A., Blaschke T. F. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986 Dec;239(3):802–807. [PubMed] [Google Scholar]
  130. Panconesi A., Franchi G., Anselmi B., Andreini R., Del Bianco P. L. Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humans. Clin Pharmacol Ther. 1988 Apr;43(4):442–448. doi: 10.1038/clpt.1988.56. [DOI] [PubMed] [Google Scholar]
  131. Prichard B. N., Walden R. J. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs. Br J Clin Pharmacol. 1982;13(Suppl 2):337S–343S. doi: 10.1111/j.1365-2125.1982.tb01938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Robinson B. F. Assessment of the effect of drugs on the venous system in man. Br J Clin Pharmacol. 1978 Nov;6(5):381–386. doi: 10.1111/j.1365-2125.1978.tb04600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Robinson B. F., Collier J. G., Dobbs R. J. Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins. Cardiovasc Res. 1979 Jan;13(1):16–21. doi: 10.1093/cvr/13.1.16. [DOI] [PubMed] [Google Scholar]
  134. Robinson B. F., Collier J. G., Karim S. M., Somers K. Effect of prostaglandins A 1 , A 2 , B 1 , E 2 and F 2 on forearm arterial bed and superficial hand veins in man. Clin Sci. 1973 Apr;44(4):367–376. doi: 10.1042/cs0440367. [DOI] [PubMed] [Google Scholar]
  135. Robinson B. F., Collier J. G. Vascular smooth muscle. Correlations between basic properties and responses of human blood-vessels. Br Med Bull. 1979 Sep;35(3):305–312. doi: 10.1093/oxfordjournals.bmb.a071593. [DOI] [PubMed] [Google Scholar]
  136. Robinson B. F., Collier J., Nachev C. Changes in peripheral venous compliance after myocardial infarction. Cardiovasc Res. 1972 Jan;6(1):67–74. doi: 10.1093/cvr/6.1.67. [DOI] [PubMed] [Google Scholar]
  137. Robinson B. F., Dobbs R. J., Kelsey C. R. Effects of nifedipine on resistance vessels, arteries and veins in man. Br J Clin Pharmacol. 1980 Nov;10(5):433–438. doi: 10.1111/j.1365-2125.1980.tb01784.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Robinson V. J., Manyari D. E., Tyberg J. V., Fick G. H., Smith E. R. Volume-pressure analysis of reflex changes in forearm venous function. A method by mental arithmetic stress and radionuclide plethysmography. Circulation. 1989 Jul;80(1):99–105. doi: 10.1161/01.cir.80.1.99. [DOI] [PubMed] [Google Scholar]
  139. Rudofsky G., Nobbe F., Ehinger W. Zur beeinflussbarkeit der venösen Hämodynamik durch thermische Reize. Med Klin. 1977 Oct 7;72(40):1639–1644. [PubMed] [Google Scholar]
  140. SJOSTRAND T. The regulation of the blood distribution in man. Acta Physiol Scand. 1952;26(4):312–327. doi: 10.1111/j.1748-1716.1952.tb00912.x. [DOI] [PubMed] [Google Scholar]
  141. SJOSTRAND T. Volume and distribution of blood and their significance in regulating the circulation. Physiol Rev. 1953 Apr;33(2):202–228. doi: 10.1152/physrev.1953.33.2.202. [DOI] [PubMed] [Google Scholar]
  142. Samani N. J. New developments in renin and hypertension. BMJ. 1991 Apr 27;302(6783):981–982. doi: 10.1136/bmj.302.6783.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Sato H., Ikenouchi H., Aoyagi T., Matsui H., Mochizuki T., Momomura S., Serizawa T., Iizuka M., Sugimoto T. Pathophysiology and evaluation of severity of congestive heart failure on the basis of venous characteristics. Jpn Circ J. 1989 Feb;53(2):141–145. doi: 10.1253/jcj.53.141. [DOI] [PubMed] [Google Scholar]
  144. Schoeffter P., Godfraind T. Spontaneous rhythmic contractions of human saphenous veins isolated from old subjects are sensitive to cyclooxygenase inhibitors. Experientia. 1989 May 15;45(5):459–461. doi: 10.1007/BF01952029. [DOI] [PubMed] [Google Scholar]
  145. Schulte K. L., Laber E., Braun J., Meyer-Sabellek W., Distler A., Gotzen R. Nifedipine vasodilates human forearm arteries and dorsal hand veins constricted by specific alpha-adrenoceptor stimulation. Gen Pharmacol. 1987;18(5):525–529. doi: 10.1016/0306-3623(87)90074-7. [DOI] [PubMed] [Google Scholar]
  146. Schulte K. L., Laber E., Meyer-Sabellek W. A., Distler A., Gotzen R. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem. J Hypertens Suppl. 1985 Dec;3(3):S239–S241. [PubMed] [Google Scholar]
  147. Sekkarie M. A., Egan B. M., Neubig R. R., Supiano M. A. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate. Clin Pharmacol Ther. 1990 Nov;48(5):537–543. doi: 10.1038/clpt.1990.190. [DOI] [PubMed] [Google Scholar]
  148. Shkhvatsabaya I. K., Erina E. V., Almusaui A. I. Venous tone in essential hypertension. Cor Vasa. 1977;19(3):184–196. [PubMed] [Google Scholar]
  149. Sicuteri F., Del Bianco P. L., Fanciullacci M., Franchi G. Il test della venocostrizione per la misura della sensibilità alla 5-idrossitriptamina e alle catecolamine nell'uomo. Boll Soc Ital Biol Sper. 1964 Oct 15;40(19):1148–1150. [PubMed] [Google Scholar]
  150. Sicuteri F., Fanciullacci M., Del Bianco P. L. Alpha and beta adrenergic receptors in human veins; activity of a new beta-blocking agent. Med Pharmacol Exp Int J Exp Med. 1966;15(1):73–78. doi: 10.1159/000135851. [DOI] [PubMed] [Google Scholar]
  151. Sicuteri F., Geppetti P., Marabini S., Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain. 1984 Apr;18(4):359–365. doi: 10.1016/0304-3959(84)90048-4. [DOI] [PubMed] [Google Scholar]
  152. Sicuteri F., Panconesi A., Del Bianco P. L., Franchi G., Anselmi B. Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis. Int J Clin Pharmacol Res. 1984;4(3):253–257. [PubMed] [Google Scholar]
  153. Sjöberg T., Norgren L., Andersson K. E., Steen S. Comparative effects of the alpha-adrenoceptor agonists noradrenaline, phenylephrine and clonidine in the human saphenous vein in vivo and in vitro. Acta Physiol Scand. 1989 Jul;136(3):463–471. doi: 10.1111/j.1748-1716.1989.tb08688.x. [DOI] [PubMed] [Google Scholar]
  154. Steen S., Castenfors J., Sjöberg T., Skärby T., Andersson K. E., Norgren L. Effects of alpha-adrenoceptor subtype-selective antagonists on the human saphenous vein in vivo. Acta Physiol Scand. 1986 Jan;126(1):15–19. doi: 10.1111/j.1748-1716.1986.tb07782.x. [DOI] [PubMed] [Google Scholar]
  155. Stein M., Deegan R., Wood A. J. Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation. Clin Pharmacol Ther. 1993 Aug;54(2):187–193. doi: 10.1038/clpt.1993.130. [DOI] [PubMed] [Google Scholar]
  156. Streeten D. H. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest. 1990 Nov;86(5):1582–1588. doi: 10.1172/JCI114878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Sudhir K., Angus J. A., Esler M. D., Jennings G. L., Lambert G. W., Korner P. I. Altered venous responses to vasoconstrictor agonists and nerve stimulation in human primary hypertension. J Hypertens. 1990 Dec;8(12):1119–1128. doi: 10.1097/00004872-199012000-00008. [DOI] [PubMed] [Google Scholar]
  158. Sumner A., Zelis R., Bennett M., Gascho J. A. Effect of the venodilated state on sympathetic-induced venoconstriction in normal subjects. Am J Cardiol. 1989 Apr 15;63(13):973–976. doi: 10.1016/0002-9149(89)90151-3. [DOI] [PubMed] [Google Scholar]
  159. Supiano M. A., Hogikyan R. V., Stoltz A. M., Orstan N., Halter J. B. Regulation of venous alpha-adrenergic responses in older humans. Am J Physiol. 1991 Apr;260(4 Pt 1):E599–E607. doi: 10.1152/ajpendo.1991.260.4.E599. [DOI] [PubMed] [Google Scholar]
  160. Takatsu H., Gotoh K., Suzuki T., Ohsumi Y., Yagi Y., Tsukamoto T., Terashima Y., Nagashima K., Hirakawa S. Quantitative estimation of compliance of human systemic veins by occlusion plethysmography with radionuclide--methodology and the effect of nitroglycerin. Jpn Circ J. 1989 Mar;53(3):245–254. doi: 10.1253/jcj.53.245. [DOI] [PubMed] [Google Scholar]
  161. Takeshita A., Ashihara T., Yamamoto K., Imaizumi T., Hoka S., Ito N., Nakamura M. Venous responses to salt loading in hypertensive subjects. Circulation. 1984 Jan;69(1):50–56. doi: 10.1161/01.cir.69.1.50. [DOI] [PubMed] [Google Scholar]
  162. Takeshita A., Mark A. L. Decreased venous distensibility in borderline hypertension. Hypertension. 1979 May-Jun;1(3):202–206. doi: 10.1161/01.hyp.1.3.202. [DOI] [PubMed] [Google Scholar]
  163. Thom S., Hughes A., Martin G., Sever P. S. Endothelium-dependent relaxation in isolated human arteries and veins. Clin Sci (Lond) 1987 Nov;73(5):547–552. doi: 10.1042/cs0730547. [DOI] [PubMed] [Google Scholar]
  164. Thulesius O., Ugaily-Thulesius L., Neglen P., Shuhaiber H. The role of the endothelium in the control of venous tone: studies on isolated human veins. Clin Physiol. 1988 Aug;8(4):359–366. doi: 10.1111/j.1475-097x.1988.tb00279.x. [DOI] [PubMed] [Google Scholar]
  165. Tsujimoto G., Lee C. H., Hoffman B. B. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther. 1986 Nov;239(2):411–415. [PubMed] [Google Scholar]
  166. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989 Oct 28;2(8670):997–1000. doi: 10.1016/s0140-6736(89)91013-1. [DOI] [PubMed] [Google Scholar]
  167. Vallance P., Collier J., Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res. 1989 Dec;23(12):1053–1057. doi: 10.1093/cvr/23.12.1053. [DOI] [PubMed] [Google Scholar]
  168. Vanhoutte P. M., Flavahan N. A. Effects of temperature on alpha adrenoceptors in limb veins: role of receptor reserve. Fed Proc. 1986 Aug;45(9):2347–2354. [PubMed] [Google Scholar]
  169. Vincent J., Blaschke T. F., Hoffman B. B. Desensitization of beta-adrenoceptor- and prostaglandin E1 receptor-mediated human vascular smooth muscle relaxation. J Cardiovasc Pharmacol. 1992 Mar;19(3):447–452. doi: 10.1097/00005344-199203000-00023. [DOI] [PubMed] [Google Scholar]
  170. Vincent J., Blaschke T. F., Hoffman B. B. Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clin Pharmacol Ther. 1992 Jan;51(1):68–75. doi: 10.1038/clpt.1992.9. [DOI] [PubMed] [Google Scholar]
  171. Vincent J., Dachman W., Blaschke T. F., Hoffman B. B. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763–1768. doi: 10.1172/JCI116050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Vincent J., Kongpatanakul S., Blaschke T. F., Hoffman B. B. Desensitization of nitrate-induced venodilation: reversal with oral N-acetylcysteine in humans. J Cardiovasc Pharmacol. 1992 Dec;20(6):907–912. doi: 10.1097/00005344-199212000-00010. [DOI] [PubMed] [Google Scholar]
  173. Vinet R., Brieva C., Pinardi G., Penna M. Modulation of alpha-adrenergic-induced contractions by endothelium-derived relaxing factor in rat aorta. Gen Pharmacol. 1991;22(1):137–142. doi: 10.1016/0306-3623(91)90324-y. [DOI] [PubMed] [Google Scholar]
  174. WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Walsh J. A., Hyman C., Maronde R. F. Venous distensibility in essential hypertension. Cardiovasc Res. 1969 Jul;3(3):338–349. doi: 10.1093/cvr/3.3.338. [DOI] [PubMed] [Google Scholar]
  176. Walters W. A., Shields L. Venous distensibility during the menstrual cycle. Br J Obstet Gynaecol. 1977 Sep;84(9):697–700. doi: 10.1111/j.1471-0528.1977.tb12683.x. [DOI] [PubMed] [Google Scholar]
  177. Webb D. J., Benjamin N., Allen M. J., Brown J., O'Flynn M., Cockcroft J. R. Vascular responses to local atrial natriuretic peptide infusion in man. Br J Clin Pharmacol. 1988 Sep;26(3):245–251. doi: 10.1111/j.1365-2125.1988.tb05273.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Webb D. J., Benjamin N., Cockcroft J. R., Collier J. G. Augmentation of sympathetic venoconstriction by angiotensin II in human dorsal hand veins. Am J Hypertens. 1989 Sep;2(9):721–723. doi: 10.1093/ajh/2.9.721. [DOI] [PubMed] [Google Scholar]
  179. Webb D. J., Cockcroft J. R. Captopril in congestive cardiac failure. BMJ. 1989 Nov 18;299(6710):1283–1283. doi: 10.1136/bmj.299.6710.1283-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Webb D. J., Haynes W. G. Venoconstriction to endothelin-1 in humans is attenuated by local generation of prostacyclin but not nitric oxide. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S317–S320. doi: 10.1097/00005344-199322008-00083. [DOI] [PubMed] [Google Scholar]
  181. Webb D. J., Seidelin P. H., Benjamin N., Collier J. G., Struthers A. D. Sympathetically mediated vasoconstriction is augmented by angiotensin II in man. J Hypertens Suppl. 1988 Dec;6(4):S542–S543. doi: 10.1097/00004872-198812040-00170. [DOI] [PubMed] [Google Scholar]
  182. White C. B., Udwadia B. P. Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline. Br J Clin Pharmacol. 1975 Apr;2(2):99–105. doi: 10.1111/j.1365-2125.1975.tb01564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Widgren B. R., Berglund G., Wikstrand J., Andersson O. K. Reduced venous compliance in normotensive men with positive family histories of hypertension. J Hypertens. 1992 May;10(5):459–465. doi: 10.1097/00004872-199205000-00009. [DOI] [PubMed] [Google Scholar]
  184. Wolzt M. Medikamentöse Beeinflussung des Gefässtonus bei Varizenträgern: vergleichende Untersuchungen mit der Venen-Compliance-Technik und der digitalen Photoplethysmographie. Wien Klin Wochenschr. 1991;103(19):591–593. [PubMed] [Google Scholar]
  185. Wolzt M., Schmidt E., Wagner B., Schuller-Petrovic S., Kyrle P. A., Eichler H. G. Effects of serotonin and noradrenaline on superficial hand veins in patients with primary hypertension and in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov;346(5):490–495. doi: 10.1007/BF00169002. [DOI] [PubMed] [Google Scholar]
  186. Yang Z. H., Diederich D., Schneider K., Siebenmann R., Stulz P., von Segesser L., Turina M., Bühler F. R., Lüscher T. F. Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein. Circulation. 1989 Oct;80(4):1041–1048. doi: 10.1161/01.cir.80.4.1041. [DOI] [PubMed] [Google Scholar]
  187. Yang Z. H., von Segesser L., Bauer E., Stulz P., Turina M., Lüscher T. F. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res. 1991 Jan;68(1):52–60. doi: 10.1161/01.res.68.1.52. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES